Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/17/2017 10/18/2017 10/19/2017 10/20/2017 10/23/2017 Date
140.5(c) 140.46(c) 145(c) 144.05(c) 140.16(c) Last
510 695 394 302 729 574 299 602 484 350 Volume
0.00% -0.03% +3.23% -0.66% -2.70% Change
More quotes
Financials ($)
Sales 2017 1 639 M
EBIT 2017 882 M
Net income 2017 392 M
Debt 2017 1 072 M
Yield 2017 -
Sales 2018 1 882 M
EBIT 2018 1 042 M
Net income 2018 553 M
Debt 2018 423 M
Yield 2018 -
P/E ratio 2017 21,84
P/E ratio 2018 15,61
EV / Sales2017 5,93x
EV / Sales2018 4,82x
Capitalization 8 652 M
More Financials
Company
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry.Its product portfolio includes: XYREM, ERWINAZETM, PRIALT,... 
Sector
Pharmaceuticals
Calendar
11/07Earnings Release
More about the company
Surperformance© ratings of Jazz Pharmaceuticals PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on JAZZ PHARMACEUTICALS PLC
09/12 JAZZ PHARMACEUTICALS : Fortune Magazine Names Jazz Pharmaceuticals 78th Fastest ..
09/01 JAZZ PHARMACEUTICALS : Announces Completion of Offering and Exercise in Full of ..
08/31 JAZZ PHARMACEUTICALS PLC : Featured Company News - Jazz Pharma to Partner with I..
08/30 JAZZ PHARMACEUTICALS : to Present at the Wells Fargo Securities Healthcare Confe..
08/29 JAZZ PHARMACEUTICALS : and ImmunoGen, Inc. Announce a Strategic Collaboration an..
08/21 JAZZ PHARMACEUTICALS PLC : Featured Company News - Jazz Pharma Offers Exchangeab..
08/18 JAZZ PHARMACEUTICALS : Announces Offering of $500 Million of 1.50% Exchangeable ..
08/17 JAZZ PHARMACEUTICALS : Announces Offering of $500 Million of Exchangeable Senior..
08/11 JAZZ PHARMACEUTICALS : Technical Snapshots for These Biotech Stocks -- ImmunoGen..
08/08 JAZZ PHARMACEUTICALS : Announces Second Quarter 2017 Financial Results
More news
Sector news : Specialty & Advanced Pharmaceuticals
07:50aDJNOVARTIS : 3Q Net Profit Rises as New Drugs Offset Generic Competition
10/23 European stocks hold firm as banks, Spanish shares fall
10/23 Smith & Nephew to buy Rotation Medical for up to $210 million
10/23DJEuropean Corporate Roundup for Monday
10/23DJDrug Makers Find 'Branded Generics' Are a Source for Growth
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on JAZZ PHARMACEUTICALS PLC 
JAZZ PHARMACEUTICALS - 2013
In an upward trend
BUY
More Strategies
Latest Tweets
08:27aJazz Pharmaceuticals PLC Forecasted to Earn Q3 2017 Earnings of $2.52 Per Sha.. 
10/23  
10/231/ Cowen earnings previews published today: $AGN $CNDT $CTSH $DPS $DXC $ENDP .. 
10/22Jazz Pharmaceuticals PLC $JAZZ Given a $177.00 Price Target by Piper Jaffray .. 
10/22Jazz Pharmaceuticals PLC given $177.00 PT by Piper Jaffray Companies. buy rat.. 
More tweets
Qtime:510
News from SeekingAlpha
10/23 GLYCOMIMETICS : Buy The Dip
10/22 More Wizardry For 2017 -- Magic Formula Large Cap Strategy Update, 2017 YTD
10/19 Premarket analyst action - healthcare
10/13 Jazz Pharmaceuticals Struggles With Sluggish Sales, High Stock Price
10/06 YOUR DAILY PHARMA SCOOP : Gilead, Some History; Biogen's Spinraza, MDCO New Data..
Chart JAZZ PHARMACEUTICALS PLC
Duration : Period :
Jazz Pharmaceuticals PLC Technical Analysis Chart | JAZZ | IE00B4Q5ZN47 | 4-Traders
Technical analysis trends JAZZ PHARMACEUTICALS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 182 $
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Bruce C. Cozadd Chairman & Chief Executive Officer
Russell J. Cox Chief Operating Officer & Executive Vice President
Matthew P. Young Chief Financial Officer & Executive Vice President
Karen L. Smith Chief Medical Officer & EVP-Research & Development
Paul Treacy Senior Vice President-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
JAZZ PHARMACEUTICALS PLC28.55%8 652
ABBVIE53.47%153 193
MERCK KGAA-5.86%14 304
KYOWA HAKKO KIRIN CO LTD26.08%10 266
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD39.22%5 811
CONVATEC GROUP-8.94%5 505